Chewy ( (CHWY) ) has issued an announcement.
On April 24, 2025, Chewy, Inc. expanded its board of directors from thirteen to fourteen members by appointing Dr. Nat Goldhaber as a Class I director, with his term set to expire at the company’s annual meeting of stockholders in 2026. Dr. Goldhaber, an independent director under SEC and NYSE rules, brings extensive experience in venture capital, clean energy, and healthcare investments, having co-founded Claremont Creek Ventures. His appointment is expected to enhance Chewy’s strategic direction, leveraging his expertise in technology and energy sectors.
Spark’s Take on CHWY Stock
According to Spark, TipRanks’ AI Analyst, CHWY is a Outperform.
Chewy’s overall stock score of 76 reflects its strong financial performance and positive earnings call, which highlight revenue growth, profitability, and cash flow strength. Technical indicators show positive momentum, although high valuation and operational efficiency remain areas for improvement.
To see Spark’s full report on CHWY stock, click here.
More about Chewy
YTD Price Performance: 6.38%
Average Trading Volume: 5,692,618
Technical Sentiment Signal: Sell
Current Market Cap: $14.9B
For a thorough assessment of CHWY stock, go to TipRanks’ Stock Analysis page.